Nestlé Health Science invests in Aimmune Therapeutics
7 November 2016 | By New Food
Nestlé Health Science has announced that it will make an equity investment of USD 145 million in US-based Aimmune Therapeutics, which corresponds to a 15% stake after completion of the transaction...